Atlas Genetics is bringing to market the first point-of-care molecular diagnostic test for chlamydia that can deliver results in 30 minutes. The rapid turnaround time will hopefully reduce the number of patients who do not go back to retrieve their results and consequently not get the necessary treatment should they have the sexually transmitted infection (STI).
The UK firm today announced it has CE marked its io CT (Chlamydia trachomatris) test, enabling it to start selling the product in Europe. However, the firm plans to conduct...